The Indian subsidiary of the German specialty chemicals giant, LANXESS AG, recently donated six ventilators worth over Rs 10 million ($136,318) to Kaushalya Medical Foundation Trust Hospital and Bethany Hospital in Thane, near Mumbai. The hospitals received three ventilators each. The donation was part of LANXESS India’s attempt to help combat the coronavirus pandemic and occurred as part of the company’s CSR initiative for 2020-2021.
LANXESS India has been proactively collaborating with authorities and medical institutions, in its concerted efforts to help the local community in fighting the pandemic. Over the past months, the company has undertaken various initiatives to mitigate the impact of COVID-19, including providing financial support of Rs 20 million ($272,606) to the Prime Minister’s Citizen Assistance and Relief in Emergency Situations Fund (PM CARES) and donation of relief material worth Rs 3 million ($40,880) to local authorities in the states of Maharashtra, Madhya Pradesh and Gujarat. This also included collaboration with the Akshaya Patra Foundation, through which the company provided over 30,000 free meals to the needy.
Additionally, the company helped in reducing cross contamination, by donating 1 tonne of its highly effective surface disinfectant, Rely+On™ Virkon™ to the BMC and TMC through the Government of Maharashtra relief co-ordination center.
Commenting on the donation, Dr. Sameep Sohoni, MS Ortho, DNB O Ortho, FICS(USA),Consultant Orthopaedic and Joint Replacement Surgeon, Kaushalya Medical Foundation Trust Hospital said, “We are grateful to LANXESS India for donating these ventilators to us as it is the most important equipment which is required in the management of Covid patients in ICU and who have low oxygen levels.”
Thanking LANXESS for its support, Vijay Lakka, COO, Bethany Hospital said, “LANXESS India’s donation of these high-end ventilators at this juncture enables our hospital to try save more lives, especially when there is a huge shortage globally for critical-care equipment. These specific ventilators equipped with High-flow nasal oxygen (HFNO) therapy can provide respiratory support for patients with acute hypoxemic respiratory failure and can also prevent subsequent intubation in this pandemic situation.”
Neelanjan Banerjee, Vice Chairman and Managing Director, LANXESS India noted that during these challenging times, medical institutions and their infrastructure have witnessed tremendous stress. “Our contribution is specially aimed at making critical care available and enhancing life-saving infrastructure in these hospitals. We are hoping to make a significant difference in our society and will continue to help the community at large in fighting the pandemic.”